title: Validity of composite end points in clinical trials.
authors.affiliation: Department of Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
authors.forename: Victor M
authors.initials: VM
authors.lastname: Montori
authors.forename: Gaietà
authors.initials: G
authors.lastname: Permanyer-Miralda
authors.forename: Ignacio
authors.initials: I
authors.lastname: Ferreira-González
authors.forename: Jason W
authors.initials: JW
authors.lastname: Busse
authors.forename: Valeria
authors.initials: V
authors.lastname: Pacheco-Huergo
authors.forename: Dianne
authors.initials: D
authors.lastname: Bryant
authors.forename: Jordi
authors.initials: J
authors.lastname: Alonso
authors.forename: Elie A
authors.initials: EA
authors.lastname: Akl
authors.forename: Antònia
authors.initials: A
authors.lastname: Domingo-Salvany
authors.forename: Edward
authors.initials: E
authors.lastname: Mills
authors.forename: Ping
authors.initials: P
authors.lastname: Wu
authors.forename: Holger J
authors.initials: HJ
authors.lastname: Schünemann
authors.forename: Roman
authors.initials: R
authors.lastname: Jaeschke
authors.forename: Gordon H
authors.initials: GH
authors.lastname: Guyatt
mesh_terms: D023381:Endpoint Determination; D006801:Humans; D016032:Randomized Controlled Trials as Topic / Q000592:standards*; D012680:Sensitivity and Specificity